Wija Oortwijn
Overview
Explore the profile of Wija Oortwijn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stinissen L, Kools J, Bouma S, Lenssen E, Sanders E, Lanser A, et al.
J Neuromuscul Dis
. 2025 Mar;
:22143602241313117.
PMID: 40034007
Background: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary muscle disease without an available cure. The first trials with potentially disease-modifying therapies have started, including a phase ll open-label study and...
2.
Botwright S, Sittimart M, Chavarina K, Bayani D, Merlin T, Surgey G, et al.
Value Health
. 2025 Jan;
PMID: 39772378
Objectives: Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, process, and use, thereby enhancing the legitimacy of...
3.
Botwright S, Sittimart M, Chavarina K, Bayani D, Merlin T, Surgey G, et al.
Int J Technol Assess Health Care
. 2025 Jan;
40(1):e74.
PMID: 39760423
Objectives: Health technology assessment (HTA) guidelines are intended to support the successful implementation of HTA by enhancing consistency and transparency in concepts, methods, processes, and use, thereby enhancing the legitimacy...
4.
Bijlmakers L, Egeli P, Al Saeedi A, Sadoon B, Richter D, Oortwijn W
Int J Technol Assess Health Care
. 2024 Dec;
40(1):e80.
PMID: 39690753
Objective: This paper reports on the process used to embark on one of the core strategies of Abu Dhabi's Department of Health, which was to develop a roadmap for HTA...
5.
Migliore A, Mueller D, Oortwijn W
Int J Technol Assess Health Care
. 2024 Nov;
40(1):e38.
PMID: 39494828
No abstract available.
6.
Refolo P, Duthie K, Hofmann B, Stanak M, Bertelsen N, Bloemen B, et al.
Int J Technol Assess Health Care
. 2024 Nov;
40(1):e39.
PMID: 39494823
Since its inception, Health Technology Assessment (HTA) has typically determined the value of a technology by collecting information derived from randomized clinical trials (RCTs), in line with the principles of...
7.
Surgey G, Curocichin G, Garabajiu M, Novakovic T, Pana A, Oortwijn W
F1000Res
. 2024 Oct;
13:518.
PMID: 39464776
Background: Moldova strives for universal health coverage (UHC) and considers health technology assessment (HTA) an important policy instrument to inform the choice of services that should be covered to progressively...
8.
van de Camp S, Stinissen L, Huseth A, Simon B, Ryan J, Sarkozy A, et al.
J Neuromuscul Dis
. 2024 Aug;
11(5):1067-1083.
PMID: 39150833
Background And Objective: Pathogenic variants of RYR1, the gene encoding the principal sarcoplasmic reticulum calcium release channel (RyR1) with a crucial role in excitation-contraction coupling, are among the most common...
9.
Oortwijn W, Jansen M, Bijlmakers L, Surgey G, Baltussen R
Int J Health Policy Manag
. 2024 Aug;
13:8647.
PMID: 39099477
No abstract available.
10.
Oortwijn W, Reijmerink W, Bussemaker J
Health Res Policy Syst
. 2024 Jul;
22(1):81.
PMID: 38978042
Background: Scientific research and innovation can generate societal impact via different pathways. Productive interactions, such as collaboration between researchers and relevant stakeholders, play an important role and have increasingly gained...